JW (Cayman) Therapeutics (HKG:2126) appointed Min Liu, the company's current CEO, as the board's chairman, effective March 13, according to a Friday filing with the Hong Kong bourse.
Liu succeeds Yiping James Li, who stepped down earlier as CEO and remained interim chairman to ensure a smooth transition for the business.
The company's shares were 8% higher at the end of trading.